Home / Aprepitant / Germany
DE ATC A04AD12 · updated 2 Nov 2026
Aprepitant shortage in Germany
Is there an Aprepitant shortage in Germany?
Yes. As of 2 Nov 2026, 6 Aprepitant products are reported short in Germany, the first since 1 Aug 2024. The company estimate for the return is 8 Dec 2026 (latest 30 Apr 2027). Main reason: increased demand.
Also short in United States, Canada, France, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Aprepitant AL 125 mg Hartkapseln | ALIUD PHARMA GmbH | 1 Aug 2024 | 8 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Aprepitant STADA 125 mg und 80 mg Hartkapseln | STADAPHARM GmbH | 5 Aug 2024 | 14 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Aprepitant AL 80 mg Hartkapseln | ALIUD PHARMA GmbH | 1 Nov 2024 | 11 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Aprepitant STADA 125 mg Hartkapseln | STADAPHARM GmbH | 17 Feb 2025 | 14 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Aprepitant AL 125 mg und 80 mg Hartkapseln | ALIUD PHARMA GmbH | 1 Sep 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Aprepitant Zentiva 80 mg und 125 mg Hartkapseln | Zentiva Pharma GmbH | 1 Oct 2025 | 30 Apr 2027 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.